Sumycin and Lipitor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumycin (tetracycline hydrochloride) and Lipitor (atorvastatin calcium). Common drug interactions include irritable bowel syndrome among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Sumycin and Lipitor. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Sumycin?

Sumycin has active ingredients of tetracycline hydrochloride. eHealthMe is studying from 145 Sumycin users. Check the latest studies of Sumycin.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.



On Jul, 30, 2026

14 people who take Sumycin and Lipitor together, and have interactions are studied.

Sumycin and Lipitor drug interactions.

What are the common drug interactions of Sumycin and Lipitor, by gender? *:

female:

  1. Irritable bowel syndrome
  2. Neuropathy peripheral (surface nerve damage)
  3. Proctitis (inflammation of the rectum and anus)
  4. Chest pain
  5. Back pain
  6. Cardiac disorder
  7. Gastritis (inflammation of stomach)
  8. Hyperglycaemia (high blood sugar)
  9. Hyperprolactinaemia (abnormally high levels of prolactin in the blood)
  10. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Anaemia (lack of blood)
  4. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  5. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  6. Arrhythmia (irregular heartbeat)
  7. Arthralgia (joint pain)
  8. Asthenia (weakness)
  9. Benign prostatic hyperplasia (benign enlargement of the prostate)
  10. Body tinea (ringworm of the body)

What are the common drug interactions of Sumycin and Lipitor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Tardive dyskinesia (a disorder that involves involuntary movements)
  3. Neuropathy peripheral (surface nerve damage)
  4. Type 2 diabetes mellitus
  5. Weight increased

50-59:

  1. Cardiac disorder
  2. Chest pain
  3. Chronic kidney disease
  4. Hyperglycaemia (high blood sugar)
  5. Hyperprolactinaemia (abnormally high levels of prolactin in the blood)
  6. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  7. Oedema peripheral (superficial swelling)
  8. Renal failure (kidney dysfunction)
  9. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

60+:

  1. Chronic kidney disease
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Renal disorder (kidney disease)
  7. Renal failure (kidney dysfunction)
  8. Right ventricular failure (right half of the heart fails to work)
  9. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

  1. Depression: 4 people, 28.57%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 21.43%
  3. High Blood Pressure: 3 people, 21.43%
  4. Age-Related Macular Degeneration: 2 people, 14.29%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 14.29%
  6. Blood Potassium Decreased: 2 people, 14.29%
  7. Chest Pain: 2 people, 14.29%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 14.29%
  9. Diabetes: 2 people, 14.29%
  10. Gastric Ulcer (stomach ulcer): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Sumycin and Lipitor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sumycin and Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lipitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on tetracycline hydrochloride and atorvastatin calcium (the active ingredients of Sumycin and Lipitor, respectively), and Sumycin and Lipitor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: